Rite Aid Corp. (RAD) gains 1.68% for July 21

Equities Staff  |

Rite Aid Corp. (NYSE: RAD) shares gained 1.68%, or $0.26 per share, to close Wednesday at $15.76. After opening the day at $15.49, shares of Rite Aid. fluctuated between $15.90 and $15.22. 2,528,692 shares traded hands a decrease from their 30 day average of 3,928,264. Wednesday's activity brought Rite Aid.’s market cap to $868,168,157.

Rite Aid. is headquartered in Camp Hill, Pennsylvania, and employs more than 53,100 people.

About Rite Aid Corp.

Rite Aid Corporation is on the front lines of delivering healthcare services and retail products to more than 1.6 million Americans daily. Our pharmacists are uniquely positioned to engage with customers and improve their health outcomes. The company provides an array of whole being health products and services for the entire family through over 2,400 retail pharmacy locations across 17 states. Through Elixir, we provide pharmacy benefits and services to approximately 4 million members nationwide.

Visit Rite Aid Corp.’s profile for more information.

About The New York Stock Exchange

The New York Stock Exchange is the world’s largest stock exchange by market value at over $26 trillion. It is also the leader for initial public offerings, with $82 billion raised in 2020, including six of the seven largest technology deals. 63% of SPAC proceeds in 2020 were raised on the NYSE, including the six largest transactions.

To get more information on Rite Aid Corp. and to follow the company’s latest updates, you can visit the company’s profile page here: Rite Aid Corp.’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content